Table 2 Multivariate analysis of FGFR-related genes for overall survival in cohort 1
From: FGFR1 expression defines clinically distinct subtypes in pancreatic cancer
Factors | Hazard ratio (95% CI) | P value |
|---|---|---|
FGFR1 | ||
FGFR1 (high vs. low) | 0.524 (0.281–0.977) | 0.042 |
Tumor grade (1, 2 vs. 3, 4) | 0.585 (0.337–1.016) | 0.057 |
Tumor stage (1, 2 vs. 3, 4) | 0.814 (0.427–1.548) | 0.530 |
FGFR4 | ||
FGFR4 (high vs. low) | 0.975 (0.516–1.842) | 0.937 |
Tumor grade (1, 2 vs. 3, 4) | 0.514 (0.263–1.002) | 0.051 |
Tumor stage (1, 2 vs. 3, 4) | 1.109 (0.614–2.001) | 0.732 |
KLB | ||
KLB (high vs. low) | 0.640 (0.375–1.093) | 0.102 |
Tumor grade (1, 2 vs. 3, 4) | 0.547 (0.316–0.945) | 0.031 |
Tumor stage (1, 2 vs. 3, 4) | 1.082 (0.606–1.931) | 0.791 |